Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander P Benz

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Open Heart|April 22, 2021
Heart rate and adverse outcomes in patients with prevalent atrial fibrillationGiorgio Moschovitis, Linda S B Johnson, Steffen Blum, et al.
Heart Rhythm|August 2, 2025
Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: A subgroup analysis of ARTESiALucas Yixi Xing, Renato Delascio Lopes, William Finlay McIntyre, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|February 24, 2021
Incidence and recurrence of new-onset atrial fibrillation detected during hospitalization for non-cardiac surgery: a systematic review and meta-analysisWilliam F McIntyre, Maria E Vadakken, Anand S Rai, et al.
Annals of Neurology|September 30, 2024
Prevalence and Distribution of Intracranial Vessel Occlusion on Angiography and Its Association with Functional Outcome in Patients with Atrial Fibrillation Presenting with Ischemic StrokeAlexander P Benz, Thomas R Meinel, Alexander Salerno, et al.
The Lancet. Neurology|January 25, 2025
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trialAshkan Shoamanesh, Thalia S Field, Shelagh B Coutts, et al.
European Journal of Heart Failure|April 13, 2026
Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiAMaria Hee Jung Park Frausing, William F McIntyre, Jeff S Healey, et al.
Journal of the American College of Cardiology|July 17, 2024
Apixaban vs Aspirin According to CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiARenato D Lopes, Christopher B Granger, Daniel M Wojdyla, et al.
European Heart Journal|September 2, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trialsRenate B Schnabel, Juan Benezet-Mazuecos, Nina Becher, et al.
Circulation|January 5, 2022
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and SexAnthony P Carnicelli, Hwanhee Hong, Stuart J Connolly, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Open Heart|April 22, 2021
Heart rate and adverse outcomes in patients with prevalent atrial fibrillationGiorgio Moschovitis, Linda S B Johnson, Steffen Blum, et al.
Heart Rhythm|August 2, 2025
Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: A subgroup analysis of ARTESiALucas Yixi Xing, Renato Delascio Lopes, William Finlay McIntyre, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|February 24, 2021
Incidence and recurrence of new-onset atrial fibrillation detected during hospitalization for non-cardiac surgery: a systematic review and meta-analysisWilliam F McIntyre, Maria E Vadakken, Anand S Rai, et al.
Annals of Neurology|September 30, 2024
Prevalence and Distribution of Intracranial Vessel Occlusion on Angiography and Its Association with Functional Outcome in Patients with Atrial Fibrillation Presenting with Ischemic StrokeAlexander P Benz, Thomas R Meinel, Alexander Salerno, et al.
The Lancet. Neurology|January 25, 2025
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trialAshkan Shoamanesh, Thalia S Field, Shelagh B Coutts, et al.
European Journal of Heart Failure|April 13, 2026
Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiAMaria Hee Jung Park Frausing, William F McIntyre, Jeff S Healey, et al.
Journal of the American College of Cardiology|July 17, 2024
Apixaban vs Aspirin According to CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiARenato D Lopes, Christopher B Granger, Daniel M Wojdyla, et al.
European Heart Journal|September 2, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trialsRenate B Schnabel, Juan Benezet-Mazuecos, Nina Becher, et al.
Circulation|January 5, 2022
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and SexAnthony P Carnicelli, Hwanhee Hong, Stuart J Connolly, et al.
Pageof 8